Hybrid~4 wks to decision Source verified 2026-11-05
Annals of Oncology
Published by European Society for Medical Oncology (ESMO) / Elsevier
Official journal of ESMO covering systemic cancer therapy, immuno-oncology, precision oncology, and phase I–III clinical trials.
Core Submission Checklist & Author Requirements
- Structured abstract (Background, Patients and methods, Results, Conclusions) and Highlights bullets
- Clinical trial registration number in abstract
- CONSORT 2025 or REMARK biomarker reporting checklist
Submission Requirements by Article Type
Original Research Specifications
Main manuscript text excluding references and supplementary material.
Main Text Limit
3,500 words
Abstract Cap
300 words
Displays (Figures & Tables)
Max 6
Peer Review Model
Single-blind
Reporting Guidelines
CONSORT 2025 or REMARK biomarker reporting checklist
Ensure manuscript adheres to the appropriate EQUATOR Network guideline.
AI Writing & Image Policy
Authors must disclose the use of generative AI tools in the Methods or Acknowledgments. AI cannot be credited as an author; humans retain full accountability.
Figure policy: Human review mandatory
Publishing Fees / APC: No submission fee; hybrid open access option available
Data verified from official publisher guidelines at https://www.annalsofoncology.org/content/authorinfo